Cargando…

Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions

BACKGROUND: To explore potential value of guard-wire technology during percutaneous coronary intervention (PCI) in patients with ostial coronary lesions. METHODS: Patients, who underwent PCI, were collected between October 2011 and March 2017. Of the 141 patients, 63 (44.7%) have ostial lesions, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqiong, Zong, Xuemei, Li, Bingqiang, Han, Zhanying, Duan, Xinjie, Li, Ying, Zhang, Jing, Wang, Yaohui, Wang, Yaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678209/
https://www.ncbi.nlm.nih.gov/pubmed/33213381
http://dx.doi.org/10.1186/s12872-020-01779-5
_version_ 1783612109553139712
author Wang, Xiaoqiong
Zong, Xuemei
Li, Bingqiang
Han, Zhanying
Duan, Xinjie
Li, Ying
Zhang, Jing
Wang, Yaohui
Wang, Yaoli
author_facet Wang, Xiaoqiong
Zong, Xuemei
Li, Bingqiang
Han, Zhanying
Duan, Xinjie
Li, Ying
Zhang, Jing
Wang, Yaohui
Wang, Yaoli
author_sort Wang, Xiaoqiong
collection PubMed
description BACKGROUND: To explore potential value of guard-wire technology during percutaneous coronary intervention (PCI) in patients with ostial coronary lesions. METHODS: Patients, who underwent PCI, were collected between October 2011 and March 2017. Of the 141 patients, 63 (44.7%) have ostial lesions, and 78 (55.3%) have distal bifurcation sites. They were divided into group A (n = 71) and group B (n = 70). Group A received PCI after guard-wire technology. Group B were given balloon dilation and stent after placing guide wire through target lesion vessel. X-ray exposure time, contrast agent dosage, total PCI duration, pressure incarceration times, cases of malignant arrhythmia and cases of failed PCI of all patients were analyzed, respectively. RESULTS: The general clinical characteristics includes patients age, sex ratio, the proportion of complications, smoking ratio and left ventricular ejection fraction of both groups was not significantly different. X-ray exposure time, contrast agent dosage, PCI total time, stent positioning time, pressure infestation frequency, arrhythmia frequency and complication number of group B were higher than those of group A. There is no case of malignant arrhythmia and case of failed PCI in group A, while there were five malignant arrhythmia and four failed PCI in group B. Contrast agent dosage and cases of failed PCI increased in group B compared with group A. CONCLUSION: The guard wire technology is safer and more feasible to patients with ostial coronary lesions who underwent PCI.
format Online
Article
Text
id pubmed-7678209
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76782092020-11-20 Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions Wang, Xiaoqiong Zong, Xuemei Li, Bingqiang Han, Zhanying Duan, Xinjie Li, Ying Zhang, Jing Wang, Yaohui Wang, Yaoli BMC Cardiovasc Disord Research Article BACKGROUND: To explore potential value of guard-wire technology during percutaneous coronary intervention (PCI) in patients with ostial coronary lesions. METHODS: Patients, who underwent PCI, were collected between October 2011 and March 2017. Of the 141 patients, 63 (44.7%) have ostial lesions, and 78 (55.3%) have distal bifurcation sites. They were divided into group A (n = 71) and group B (n = 70). Group A received PCI after guard-wire technology. Group B were given balloon dilation and stent after placing guide wire through target lesion vessel. X-ray exposure time, contrast agent dosage, total PCI duration, pressure incarceration times, cases of malignant arrhythmia and cases of failed PCI of all patients were analyzed, respectively. RESULTS: The general clinical characteristics includes patients age, sex ratio, the proportion of complications, smoking ratio and left ventricular ejection fraction of both groups was not significantly different. X-ray exposure time, contrast agent dosage, PCI total time, stent positioning time, pressure infestation frequency, arrhythmia frequency and complication number of group B were higher than those of group A. There is no case of malignant arrhythmia and case of failed PCI in group A, while there were five malignant arrhythmia and four failed PCI in group B. Contrast agent dosage and cases of failed PCI increased in group B compared with group A. CONCLUSION: The guard wire technology is safer and more feasible to patients with ostial coronary lesions who underwent PCI. BioMed Central 2020-11-19 /pmc/articles/PMC7678209/ /pubmed/33213381 http://dx.doi.org/10.1186/s12872-020-01779-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Wang, Xiaoqiong
Zong, Xuemei
Li, Bingqiang
Han, Zhanying
Duan, Xinjie
Li, Ying
Zhang, Jing
Wang, Yaohui
Wang, Yaoli
Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions
title Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions
title_full Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions
title_fullStr Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions
title_full_unstemmed Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions
title_short Potential value of guard-wire technology in the interventional treatment for ostial coronary lesions
title_sort potential value of guard-wire technology in the interventional treatment for ostial coronary lesions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678209/
https://www.ncbi.nlm.nih.gov/pubmed/33213381
http://dx.doi.org/10.1186/s12872-020-01779-5
work_keys_str_mv AT wangxiaoqiong potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT zongxuemei potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT libingqiang potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT hanzhanying potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT duanxinjie potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT liying potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT zhangjing potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT wangyaohui potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions
AT wangyaoli potentialvalueofguardwiretechnologyintheinterventionaltreatmentforostialcoronarylesions